Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
Biochemical Pharmacology|March 20, 2025
Targeting RBM39 with Tasisulam enhances TRAIL-induced apoptosis through DR5 upregulation and Bcl-2 downregulation in renal cell carcinomaJi Hoon Jang, Haein Kim, Heejin Jun, et al.BMC Neurology|March 11, 2020
Serum α-synuclein and IL-1β are increased and correlated with measures of disease severity in children with epilepsy: potential prognostic biomarkers?Jieun Choi, Soo Yeon Kim, Hunmin Kim, et al.Developmental Medicine and Child Neurology|August 2, 2025
Clinical features and outcomes of paediatric probable antibody-negative autoimmune encephalitisHye Jin Kim, Jong Ho Cha, Woojoong Kim, et al.Neuromuscular Disorders : NMD|September 2, 2019
Chronic inflammatory demyelinating polyneuropathy: Plasmapheresis or cyclosporine can be good treatment options in refractory casesWooJoong Kim, Young Kyu Shim, Sun Ah Choi, et al.Journal of Clinical Neurology (Seoul, Korea)|January 17, 2020
Clinical and Genetic Spectrum of <i>ATP1A3</i>-Related Disorders in a Korean Pediatric PopulationWoo Joong Kim, Young Kyu Shim, Sun Ah Choi, et al.Neuromuscular Disorders : NMD|April 23, 2023
Broad spectrum of phenotype and genotype in Korean α-dystroglycan related muscular dystrophy presenting to a tertiary pediatric neuromuscular centerYoung Jun Ko, Anna Cho, Woo Joong Kim, et al.Pediatric Emergency Care|July 26, 2014
Effectiveness of intravenous levetiracetam as an adjunctive treatment in pediatric refractory status epilepticusJon Soo Kim, Jeong Ho Lee, Hye Won Ryu, et al.Journal of Clinical Neurology (Seoul, Korea)|January 8, 2025
Phenotype of Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in ChildrenJi Yeon Han, Soo Yeon Kim, Woojoong Kim, et al.Seizure|February 27, 2026
Toward practical standardization: Development of clinical common data elements for pediatric epilepsy in Korea and exploration of their clinical utilityJaeso Cho, Hee Jeong Yun, Hyun Woo Kim, et al.American Journal of Medical Genetics. Part A|April 2, 2024
SYNGAP1-related developmental and epileptic encephalopathy: Genotypic and phenotypic characteristics and longitudinal insightsHye Jin Kim, Minhye Kim, Seoyun Jang, et al.Pageof 8